Eun Joo Kang
Overview
Explore the profile of Eun Joo Kang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
93
Citations
1057
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee K, Kim T, Yong Lee S, Lee Y, Choi J, Choi J, et al.
Lung Cancer
. 2025 Feb;
201:108455.
PMID: 39987792
Background: The combination of atezolizumab with etoposide and carboplatin (AECb) has become a new standard of care for extensive-stage small-cell lung cancer (ES-SCLC). This study evaluates its impact on central...
2.
Joo Kang E, Hwang S, Lee Y, Choi J, Shin S, Choi Y, et al.
Cancer Res Treat
. 2024 Dec;
PMID: 39727015
Purpose: TP53 mutations are common in head and neck squamous cell carcinoma (HNSCC). We evaluated their clinical impact in patients treated with targeted agents or immunotherapy in the KCSG HN15-16...
3.
Choi J, Thirupathi A, Kim J, Ha H, Ahn K, Joo Kang E
J Org Chem
. 2024 Dec;
89(24):18081-18089.
PMID: 39630108
This study presents the application of a novel Fe-iminopyridine catalyst for the regioselective synthesis of oxazolidinones from carbon dioxide and aziridines. Our findings demonstrate that the Fe-iminopyridine catalyst containing imidazole...
4.
Kang E, Kang J, Koh S, Kim Y, Seo S, Kim J, et al.
JAMA Netw Open
. 2024 Aug;
7(8):e2426304.
PMID: 39115845
Importance: Limited data suggest that early palliative care (EPC) improves quality of life (QOL) and survival in patients with advanced cancer. Objective: To evaluate whether comprehensive EPC improves QOL; relieves...
5.
Jeon M, Noh E, Moon S, Yu E, Choi C, Kim D, et al.
Cancer Res Treat
. 2024 May;
56(4):1262-1269.
PMID: 38726507
Purpose: Numerous patients experience long-term complications after hematopoietic stem cell transplantation (HSCT). This study aimed to identify the frequency and risk factors for psychiatric and endocrine complications following HSCT through...
6.
Kim Y, Keam B, Joo Kang E, Kim J, Kim H, Lee K, et al.
Cancer Res Treat
. 2024 Apr;
56(4):1068-1076.
PMID: 38637966
Purpose: In this study, we evaluated 66 patients diagnosed with adenoid cystic carcinoma (ACC) enrolled in two Korean Cancer Study Group trials to investigate the response and progression patterns in...
7.
Han G, You J, Choi J, Joo Kang E
Org Lett
. 2024 Mar;
26(12):2414-2419.
PMID: 38489286
We present an innovative photoinduced cyanoalkyl radical addition methodology using -iminopyridinium reagents derived from cyclic ketones. Mechanistic investigations reveal the association of the excited Hantzsch ester and iminopyridinium with pyridyl...
8.
Kim J, Lee H, Lee J, Park S, Kim Y, Hwang I, et al.
J Immunother Cancer
. 2024 Mar;
12(3).
PMID: 38485184
Background: Immune-modulating antibodies targeting programmed cell death protein 1/programmed death-ligand 1 (PD-1/PD-L1) have demonstrated promising antitumor efficacy in various types of cancers, especially highly mutated ones. Genetic alterations in DNA...
9.
Kim D, Lim S, Kim H, Joo Kang E, Ahn H, Lee Y, et al.
Oral Oncol
. 2024 Mar;
151:106739.
PMID: 38458039
Objectives: This study aimed to investigate whether genetic alterations in PI3KCA and the cell cycle pathways influence the efficacy of durvalumab, an immune checkpoint inhibitor, in patients with head and...
10.
Jang J, Cha I, Choi J, Han J, Hwang J, Cho I, et al.
Polymers (Basel)
. 2024 Jan;
16(2).
PMID: 38256976
Recent environmental concerns have increased demand for renewable polymers and sustainable green resource usage, such as biomass-derived components and carbon dioxide (CO). Herein, we present crosslinked polyurethanes (CPUs) fabricated from...